SCHEMBL1979202

SCHEMBL1979202

c1ccc2cc3c(cc2c1)-c1cc2ccccc2cc1-c1cc2ccccc2cc1-c1cc2ccccc2cc1-3

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.67
HSD17B10 Q99714 7/20 0.67
CASP1 P29466 4/20 0.67
HIF1A Q16665 4/20 0.67
HPGD P15428 4/20 0.67
TSHR P16473 4/20 0.67
CASP7 P55210 3/20 0.67
MAPK1 P28482 3/20 0.67
TP53 P04637 2/20 0.67
CYP2A6 P11509 7/20 0.54
ALOX12 P18054 1/20 0.54
NQO2 P16083 1/20 0.47
CYP1A2 P05177 3/20 0.45
TDP1 Q9NUW8 3/20 0.45
CYP3A4 P08684 2/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
HBB P68871 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9042905 1.00 ALDH1A1 (0.67) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL28763536 1.00 ALDH1A1 (0.67) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL5917389 1.00 ALDH1A1 (0.67) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL1811522 1.00 ALDH1A1 (0.67) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL1154675 1.00 ALDH1A1 (0.67) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL9039265 0.93 ALDH1A1 (0.68) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL16200967 0.87 ALDH1A1 (0.55) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL30458681 0.84 MEN1 (0.53) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL16144676 0.84 MEN1 (0.53) ALDH1A1HSD17B10CASP1HIF1AHPGD
SCHEMBL19230417 0.84 ALDH1A1 (0.52) ALDH1A1HSD17B10CASP1HIF1AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115926856-A Microcrystal material adsorption equipment for coke gas purification 上海锐昊环保科技有限公司 2023-04-07 CN claimed
EP-2260035-B1 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX KK (JP) 2014-08-20 EP claimed
US-20110149393-A1 Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof Crysoptic KK (JP) 2011-06-23 US claimed
EP-2260035-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2010-12-15 EP claimed
WO-2009109781-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2009-09-11 WO claimed
US-20250282621-A1 CARBON NANOTUBE COMPOSITE COMPRISING MECHANICAL L IGANDS NANOCORE APS (DK) 2025-09-11 US disclosed
US-12227625-B2 Composite materials comprising mechanical ligands NANOCORE APS (DK) 2025-02-18 US disclosed
EP-4363373-A1 CARBON NANOTUBE COMPOSITE COMPRISING MECHANICAL LIGANDS Nanocore ApS (DK) 2024-05-08 EP disclosed
US-11834559-B2 Composite materials with desired characteristics NANOCORE APS (DK) 2023-12-05 US disclosed
CN-115926856-A Microcrystal material adsorption equipment for coke gas purification 上海锐昊环保科技有限公司 2023-04-07 CN disclosed
WO-2023001506-A1 CARBON NANOTUBE COMPOSITE COMPRISING MECHANICAL LIGANDS NANOCORE APS (DK) 2023-01-26 WO disclosed
EP-4119598-A1 NANOCOMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS Nanocore ApS (DK) 2023-01-18 EP disclosed
WO-2013014445-A1 DERIVATIVES OF PHENYL (THIO) UREA DEOXYTHYMIDINE AND USE THEREOF AS ANTIMALARIALS UNIVERSITY OF DUNDEE (GB) 2013-01-31 WO disclosed
US-20110149393-A1 Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof Crysoptic KK (JP) 2011-06-23 US disclosed
US-20110008471-A1 SYNERGISTIC ANTIPARASITIC COMPOSITIONS AND SCREENING METHODS TYRATECH, INC. (US) 2011-01-13 US disclosed
EP-2260035-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2010-12-15 EP disclosed
WO-2009109781-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2009-09-11 WO disclosed
JP-2000256255-A OPTICAL RESOLUTION OF (±)-TRANS-PERMETHRINIC ACID KURARAY CO LTD 2000-09-19 JP disclosed
US-5998410-A Sulfonamide derivatives ONO PHARMACEUTICALS CO., LTD. (JP) 1999-12-07 US disclosed
US-5795890-A ELASTASE INHIBITORS ONO PHARMACEUTICAL CO., LTD. (JP) 1998-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110149393-A1 Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof CCNB1, CCNB2, CCNE2 ALDH1A1 3686/4885HSD17B10 3435/4885CASP1 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.